| Profile | GDS1873 / 201834_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 373.279 | 70 |
| GSM40788 | control - Rep 2 | 450.751 | 75 |
| GSM40789 | control - Rep 3 | 392.814 | 72 |
| GSM40775 | androgen treated - Rep 1 | 410.916 | 73 |
| GSM40776 | androgen treated - Rep 2 | 320.958 | 67 |
| GSM40777 | androgen treated - Rep 3 | 381.737 | 72 |
| GSM40790 | estrogen treated - Rep 1 | 434.412 | 74 |
| GSM40791 | estrogen treated - Rep 2 | 440.096 | 74 |
| GSM40792 | estrogen treated - Rep 3 | 303.682 | 65 |
| GSM40784 | A + tamoxifen - Rep 1 | 389.213 | 71 |
| GSM40785 | A + tamoxifen - Rep 2 | 433.816 | 74 |
| GSM40786 | A + tamoxifen - Rep 3 | 387.358 | 72 |
| GSM40778 | A + anastrozole - Rep 1 | 403.436 | 74 |
| GSM40779 | A + anastrozole - Rep 2 | 474.357 | 75 |
| GSM40780 | A + anastrozole - Rep 3 | 434.313 | 74 |
| GSM40781 | A + letrozole - Rep 1 | 390.549 | 73 |
| GSM40782 | A + letrozole - Rep 2 | 480.518 | 75 |
| GSM40783 | A + letrozole - Rep 3 | 422.912 | 73 |